Nicola S. Cosgrove

123 St. Stephen's Green
Paraguay

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Correction: ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis.

Correction: ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis.

Journal: BMC medicine

Published: December 13, 2025

Case Report: Whole-genome sequencing of urothelial carcinoma in an adult patient with CLOVES syndrome reveals a lack of PIK3CA mutation and a genomic landscape consistent with urothelial carcinoma.

Case Report: Whole-genome sequencing of urothelial carcinoma in an adult patient with CLOVES syndrome reveals a lack of PIK3CA mutation and a genomic landscape consistent with urothelial carcinoma.

Journal: Frontiers in oncology

Published: September 12, 2025

Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancer.

Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancer.

Journal: Journal of the National Cancer Institute

Published: February 17, 2025

Case report: Clonal evolution analysis of a rare case of meningioma lung metastases identifies actionable alterations in matched longitudinal tumour samples.

Case report: Clonal evolution analysis of a rare case of meningioma lung metastases identifies actionable alterations in matched longitudinal tumour samples.

Journal: Frontiers in oncology

Published: August 19, 2024

Receptor Discordance in Metastatic Breast Cancer; a review of clinical and genetic subtype alterations from primary to metastatic disease.

Receptor Discordance in Metastatic Breast Cancer; a review of clinical and genetic subtype alterations from primary to metastatic disease.

Journal: Breast cancer research and treatment

Published: August 19, 2023

Steroid-free combination of 5-azacytidine and venetoclax for the treatment of multiple myeloma.

Steroid-free combination of 5-azacytidine and venetoclax for the treatment of multiple myeloma.

Journal: Haematologica

Published: June 29, 2023

Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancer.

Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancer.

Journal: NPJ breast cancer

Published: December 21, 2022

Correction to: An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancer.

Correction to: An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancer.

Journal: Cancer gene therapy

Published: December 20, 2022

An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancer.

An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancer.

Journal: Cancer gene therapy

Published: June 28, 2022

Dynamic epi-transcriptomic landscape mapping with disease progression in estrogen receptor-positive breast cancer.

Dynamic epi-transcriptomic landscape mapping with disease progression in estrogen receptor-positive breast cancer.

Journal: Cancer communications (London, England)

Published: May 03, 2022

A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis.

A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis.

Journal: EMBO molecular medicine

Published: May 14, 2021

Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities.

Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities.

Journal: Nature communications

Published: March 08, 2021

Showing 1-12 of 18

Last Updated: 09/26/2026